Efficacy and Safety of Doxazosin in Medical Expulsive Therapy for Distal Ureteral Stones: A Systematic Review and Meta-analysis
Vol. 17 No. 05 (2020),
30 October 2020
Purpose: Alpha-blockers have been proven as an effective method for increasing the stone expulsion rate of distal ureteral stones. Limited studies have focused on doxazosin; its efficacy remained unclear. We performed this meta-analysis to investigate the efficacy and safety of doxazosin for patients diagnosed with distal ureteral stones less than 10mm.
Materials and Methods: We systematically searched Ovid MEDLINE®, Cochrane Library, EMBASE, and PubMed for articles comparing doxazosin and conventional care or tamsulosin for distal ureteral stones through October 2019. The outcome measures were stone expulsive rate (SER), stone expulsive time (SET), pain episodes, analgesics consumption, and adverse events.
Results: We included 12 studies involving 836 participants with distal ureteral stones less than 10mm in our review. The present meta-analysis showed doxazosin could significantly increase SER [RR=1.64,95%CI (1.32, 2.04), P < 0.00001], shorten SET [WMD=-3.97,95% CI (-5.68, -2.27), P < 0.00001] compared with conventional care. In the subgroup analyses, doxazosin showed no benefit in the children subgroup (<16 years old) [RR=1.63,95% CI (0.73,3.64), P =0.23]. No statistically significant difference was observed regarding the effectiveness of doxazosin and tamsulosin in SER, SET, and safety. 9 in 286 participants reported doxazosin-related adverse events; most were mild to moderate.
Conclusion: This meta-analysis may suggest that doxazosin is a safe and effective MET for distal ureteral stones less than 10mm. It is not demonstrated to have any significant difference with tamsulosin in SER, SET, and safety. However, it showed no benefits for patients<16 years old.
- ureteral stones
How to Cite
Preminger GM, Tiselius H-G, Assimos DG, et al. 2007 Guideline for the Management of Ureteral Calculi. European Urology. 2007;52:1610-31.
Erturhan S, Bayrak O, Sarica K, Seckiner I, Baturu M, Sen H. Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology. 2013;81:640-3.
Yuceturk CN, Dadali M, Bagbanci MS, et al. Efficacy of Silodosin Dose in Medical Expulsive Therapy for Distal Ureteral Stones: A Retrospective Study. Urology journal. 2017;14:2944-8.
Sigala S, Dellabella M, Milanese G, et al. Evidence for the presence of alpha1 adrenoceptor subtypes in the human ureter. Neurourol Urodyn. 2005;24:142-8.
Tao R-z, Qin Z-q, Lv J-l. Efficacy and Safety of Tamsulosin in the Medical Expulsion Therapy for Distal Ureteral Calculi: A Systematic Review and Meta-Analysis of Placebo-Controlled Trials. Urology journal. 2019;16:224-31.
Gurbuz MC, Polat H, Canat L, Kilic M, Caskurlu T. Efficacy of three different alpha 1-adrenergic blockers and hyoscine N-butylbromide for distal ureteral stones. Int Braz J Urol. 2011;37:195-200; discussion 1-2.
Wang RC, Smith-Bindman R, Whitaker E, et al. Effect of Tamsulosin on Stone Passage for Ureteral Stones: A Systematic Review and Meta-analysis. Ann Emerg Med. 2017;69:353-61 e3.
D M, A L, J T, DG A, Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. https://www.equator-network.org/reporting-guidelines/prisma/. Accessed 2 November, 2019.
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj. 2011;343:d5928.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Vol 4. Chichester: John Wiley & Sons; 2011.
Aydogdu O, Burgu B, Gucuk A, Suer E, Soygur T. Effectiveness of doxazosin in treatment of distal ureteral stones in children. J Urol. 2009;182:2880-4.
Ayubov B, Arustamov D, Mukhtarov S. Efficacy of Doxazosin in the Management of Ureteral Stones. European Urology Supplements. 2007;6.
Celik S, Akdeniz F, Afsar Yildirim M, et al. Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones. Arch Ital Urol Androl. 2018;90:117-22.
Liatsikos EN, Katsakiori PF, Assimakopoulos K, et al. Doxazosin for the management of distal-ureteral stones. J Endourol. 2007;21:538-41.
Mshemish BA-R. A comparative study between tamsulosin and doxazosin for management of lower ureteral stones. IRAQI JOURNALOF COMMUNITY MEDICINE. 2012;25:153-7.
Mukhtarov S, Turdiev A, Fozilov A, Arustamov D, Ayubov B. Using Doxazosin for Distal Ureteral Stone Clearance with or without Shock Wave Lithotripsy. European Urology Supplements. 2007;6.
Ben R, Sallami S, Mohamed C. Comparison and Efficacy of 3 Different Alpha1-Adrenergic Blockers for Distal Ureteral Stones. Urology. 2009; 74(4):S341.
Sen H, Erturhan S, Sadioglu E, Bayrak O, Seckiner I. A comparison of efficacy of doxazosin 4 and 8 mg in medical expulsive therapy of distal ureteral stones: a prospective randomized clinical trial. Urolithiasis. 2016;45:461-4.
Yilmaz E, Batislam E, Basar MM, Tuglu D, Ferhat M, Basar H. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005;173:2010-2.
Zehri AA, Ather MH, Abbas F, Biyabani SR. Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology. 2010;75:1285-8.
Turk C, Petrik A, Sarica K, et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur Urol. 2016;69:468-74.
Chan KH, Whittam BM, Krambeck A, et al. Cost-Effectiveness Analysis of the Management of Distal Ureteral Stones in Children. Urology. 2019;127:107-12.
Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha blockers in medical expulsive therapy for ureteral stones: a mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018;11:291-307.
Campschroer T, Zhu X, Vernooij RWM, Lock T. alpha-blockers as medical expulsive therapy for ureteric stones: a Cochrane systematic review. BJU Int. 2018;122:932-45.
Seitz C, Liatsikos E, Porpiglia F, Tiselius H-G, Zwergel U. Medical therapy to facilitate the passage of stones: what is the evidence? European urology. 2009;56:455-71.
Bensalah K, Pearle M, Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. European urology. 2008;53:411-9.
Wang RC, Smith-Bindman R, Whitaker E, et al. Effect of tamsulosin on stone passage for ureteral stones: a systematic review and meta-analysis. Annals of emergency medicine. 2017;69:353-61. e3.
Tian D, Li N, Huang W, Zong H, Zhang Y. The efficacy and safety of adrenergic alpha-antagonists in treatment of distal ureteral stones in pediatric patients: A systematic review and meta-analysis. J Pediatr Surg. 2017;52:360-5.
Velazquez N, Zapata D, Wang HH, Wiener JS, Lipkin ME, Routh JC. Medical expulsive therapy for pediatric urolithiasis: Systematic review and meta-analysis. J Pediatr Urol. 2015;11:321-7.
Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. British journal of clinical pharmacology. 2012;73:691-705.
- Abstract Viewed: 0 times
- 5958 Downloaded: 0 times